Summary of Significant Accounting Policies - Additional Information (Detail)	1 Months Ended	3 Months Ended	12 Months Ended
	Feb. 28, 2021	Dec. 31, 2024 USD ($) Customer	Dec. 31, 2024 USD ($) Customer Segment	Dec. 31, 2023 USD ($) Customer	Dec. 31, 2022 USD ($)
Summary Of Significant Accounting Policies [Line Items]
Net cash used in operating activities			$ 11,359,000	$ (43,168,000)	$ (25,615,000)
Description of payment of customer invoice contract			The Company invoices its customers based upon the terms in the contracts, which generally require payment 30 to 60 days from the date of invoice.
Application of an optional exemption not to disclose the value of unsatisfied performance obligations			true
Number of major customers representing outstanding accounts receivable | Customer		1	1	3
Shelf life period, platelet kits		18 months
Inventory valuation reserves		$ 900,000	$ 900,000	$ 700,000
Number of reportable segments | Segment			1
Dispose, impair or recognition of additional goodwill			$ 0	0	0
Impairment of investments in preferred stock and warrants			$ 0	0	2,200,000
Period of warranty			1 year
Warranty claim liability		0	$ 0	$ 0
China | Cerus Zhongbaokang Shandong Biomedical Co L T D
Summary Of Significant Accounting Policies [Line Items]
Variable interest entity, Purpose of VIE			the Company entered into an Equity Joint Venture Contract with Shandong Zhongbaokang Medical Implements Co., Ltd. (“ZBK”), to establish Cerus Zhongbaokang (Shandong) Biomedical Co., LTD. (the “JV”) for the purpose of developing, obtaining regulatory approval for, and eventual manufacturing and commercialization of the INTERCEPT blood transfusion for platelets and red blood cells in the People’s Republic of China.
Ownership percentage	51.00%
Trade Accounts Receivable | Customer Concentration Risk | Customers
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			37.00%	51.00%
Other Assets
Summary Of Significant Accounting Policies [Line Items]
Cash surrender value of associated life insurance policies		2,800,000	$ 2,800,000	$ 2,600,000
Other Non-current Liabilities
Summary Of Significant Accounting Policies [Line Items]
Liability for deferred compensation		$ 3,100,000	$ 3,100,000	2,800,000
Minimum
Summary Of Significant Accounting Policies [Line Items]
Payment of customer invoice contract period			30 days
Estimated useful life of property and equipment		3 years	3 years
Maximum
Summary Of Significant Accounting Policies [Line Items]
Payment of customer invoice contract period			60 days
Percentage of deferred compensation from base salary			80.00%
Percentage of deferred compensation from variable compensation			100.00%
Shelf lives of inventory			24 months
Estimated useful life of property and equipment		5 years	5 years
Non-cash purchases of capital expenditures			$ 100,000	800,000	$ 700,000
Product
Summary Of Significant Accounting Policies [Line Items]
Contract asset		$ 0	0	0
Contract liabilities		$ 500,000	$ 500,000	$ 1,500,000